The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy
The immune system constantly monitors the emergence of cancerous cells and eliminates them. CD8<sup>+</sup> cytotoxic T lymphocytes (CTLs), which kill tumor cells and provide antitumor immunity, select their targets by recognizing tumor antigenic peptides presented by MHC class-I (MHC-I)...
Main Authors: | Akhil Shukla, Maryse Cloutier, Madanraj Appiya Santharam, Sheela Ramanathan, Subburaj Ilangumaran |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/4/1964 |
Similar Items
-
NLRC5-CIITA Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity
by: Madanraj Appiya Santharam, et al.
Published: (2023-04-01) -
The MHC Class II Transactivator CIITA: Not (Quite) the Odd-One-Out Anymore among NLR Proteins
by: Jorge Alfonso León Machado, et al.
Published: (2021-01-01) -
NLRP3, NLRC4 and NLRC5 Gene Polymorphisms Associate with Susceptibility of Pulmonary Aspergillosis in Non-Neutropenic Patients
by: Jinjin Zhong, et al.
Published: (2022-03-01) -
Inflammatory Cytokines That Enhance Antigen Responsiveness of Naïve CD8<sup>+</sup> T Lymphocytes Modulate Chromatin Accessibility of Genes Impacted by Antigen Stimulation
by: Akouavi Julite Irmine Quenum, et al.
Published: (2022-11-01) -
NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens
by: Galaxia M. Rodriguez, et al.
Published: (2024-01-01)